NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Market Update

Monday, [Date]: Benchmark indices Sensex and Nifty were trading modestly higher but pared early gains, as profit booking occurred after last week's relief rally linked to the US Supreme Court striking down President Donald Trump's tariffs. Fresh uncertainty resurfaced after Trump announced a new 15% tariff, keeping global cues fragile.

Key Indices and Performance

  • Sensex: Up 303 points (0.4%) at 83,118
  • Nifty: Gained 83 points (0.3%) to 25,654
  • Market Breadth: Weak, with 2,110 stocks declining against 1,771 advances on the NSE

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Top Gainers

  • Adani Ports and Special Economic Zone: Risen 2.3% to Rs 1,545.9
  • Kotak Mahindra Bank: Advanced 2.1% to Rs 430.1
  • HDFC Life Insurance: Climbed 1.8% to Rs 741.9
  • Dr Reddy's Laboratories: Gained 1.7% to Rs 1,302.5

Notable Losers

  • Hindalco Industries: Fell 2.4% to Rs 913.5
  • Wipro: Dropped 2.3% to Rs 205
  • Infosys: Declined 2.1% to Rs 1,325.1
  • Oil and Natural Gas Corporation: Fell 1.8% to Rs 273.6

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

Sectoral Performance

  • IT: Remained the weakest pocket, down 1.61%
  • Defensives: FMCG and pharma traded in the green
  • India VIX: Slipped 1.18% to 14.19, indicating subdued volatility

Investor Takeaway

Investors should be cautious of IT stocks amid concerns over artificial intelligence-led disruption and recent brokerage downgrades.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.